Should clinical pharmacokinetic bridging studies between Caucasian and Asian populations be required for approval of monoclonal antibodies?
- PMID: 22135052
- DOI: 10.1177/0091270011411192
Should clinical pharmacokinetic bridging studies between Caucasian and Asian populations be required for approval of monoclonal antibodies?
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
